Navigation Links
Studies shed light on preserving fertility among cancer patients
Date:7/20/2009

PITTSBURGH, July 20 Cancer treatment has come a long way, leading to a multitude of therapy options and improved survival rates. These successes, however, have created a challenge for young cancer patients since chemotherapy and radiation treatments that often save lives threaten fertility. Techniques available to safeguard fertility, such as freezing eggs for later embryo development, have poor odds of success, leaving patients with very limited options for the future. But that is beginning to change as researchers improve current techniques, mature human eggs in the laboratory, and discover cellular mechanisms that could help preserve and even restore fertility. Researchers will report on these and other findings at the 42nd annual meeting of the Society for the Study of Reproduction (SSR), July 18 to 22, at the David L. Lawrence Convention Center in Pittsburgh.

Summaries of the findings are as follows:

Growing Egg Cells in the Lab

Researchers at Northwestern University are developing a method they hope will help preserve a woman's fertility after radiation and chemotherapy treatment. Led by Teresa K. Woodruff, Ph.D., the team has grown undeveloped human eggs to near maturity in laboratory cultures. During a 30-day experiment, they grew human follicles―tiny sacs that contain immature eggs―in the lab until the eggs they contained were nearly mature. According to Dr. Woodruff, this is the first step in developing a new fertility option for young cancer patients.

Making a More Viable Embryo

Cryopreservation, the process of freezing eggs for later fertilization, has played a major role in assisted reproductive technology for the past two decades. Unfortunately, however, eggs rarely survive the freezing and thawing processes required to develop a viable embryo. A mere half of eggs survive and of these, only 20 percent, once fertilized, result in the birth of a baby. According to David Albertini, Ph.D., University of Kansas Medical Center, clinicians may be waiting too long three hours after thawing eggs to initiate fertilization with the sperm, a process necessary to create an embryo. When his research team used confocal microscopy to observe what was happening at a chromosomal level, they found that the structures needed to make the embryo's chromosomes align and divide were in place after only an hour. This indicates a shorter thawing time frame could have greater potential for success.

Restoring Fertility From the Bottom Up

Researchers at Stanford University, led by Renee A. Reijo Pera, Ph.D., have identified several genes involved in the formation of germ cells that give rise to eggs and sperm. These genes, DAZ and DAZL, form the basis of human embryo and germ cell growth and may be a key to understanding human reproductive failure one of the most common health problems in men and women and a common cause of birth defects. While continued progress in developing germ cells capable of making embryos renders fertility restoration feasible, it also raises significant ethical questions, says Dr. Reijo Pera.


'/>"/>

Contact: Clare Collins
CollCX@upmc.edu
412-647-3555
University of Pittsburgh Schools of the Health Sciences
Source:Eurekalert

Related medicine news :

1. New HIV Study Shows That Large Numbers of Women and People of Color Can Be Successfully Enrolled In U.S. HIV Clinical Studies
2. CNCB Post Graduate Studies in Clinical Nutrition (PGSCN) Program is Now Available Online
3. 105-Day Mars Simulation: U.S. Studies Focus on Improving Work Performance
4. 105-day Mars simulation: US studies focus on improving work performance
5. Analysis of Four Large Post-Marketing Surveillance Studies Describe Clinical Effects of Sucrose-Formulated Recombinant Factor VIII
6. Three New Studies Give Clear Guidance on How to Better Recruit Volunteers for Alzheimers Clinical Studies
7. Latest Studies Show Junk Drinks Pose as Many Health Threats as Junk Food According to AquaHydrate Medical Advisor
8. Video: Perot Systems Unveils Series of Healthcare Video Case Studies
9. Center receives grant renewal for hypertension and vascular disease studies
10. Prostate screening studies reviewed in European Urology July issue
11. Statement from IDF on studies suggesting possible link between insulin glargine and cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/28/2017)... ... April 28, 2017 , ... ... with the Home Care Association of America (HCAOA). This agreement allows HCAOA members ... services, as well as discounts on Accreditation University (AU) educational resources that help ...
(Date:4/28/2017)... (PRWEB) , ... April 28, 2017 , ... ... to announce the integration of Microsoft(R) Word(TM) Online(TM), which enables sleep physicians to ... since it streamlines the reporting process and provides a familiar interface that does ...
(Date:4/28/2017)... ... 2017 , ... Horizon Blue Cross Blue Shield of New Jersey (BCBSNJ) announced ... its outlook as “stable.” At the same time, the ratings agency cautioned that the ... dip below “capital adequacy” thresholds required for its strong rating. , “Horizon is committed ...
(Date:4/28/2017)... ... April 28, 2017 , ... GlycoMark, Inc. announced today ... throughout the Northeast U.S. , GlycoMark is the only clinically available blood ... provides a clinically proven one- to two-week measure of hyperglycemic excursions, often related ...
(Date:4/28/2017)... ... April 28, 2017 , ... Ushio America ... lamps offer an instant energy-saving solution for F32T8 fluorescent lamps on most instant-start ... ballasts. These 50,000 hour rated lamps utilize the existing electronic ballast, saving labor ...
Breaking Medicine News(10 mins):
(Date:4/24/2017)... 2017 Solentim, the developer of instrumentation ... of a major new product line called the ... VIPS has been developed for automatically seeding single ... part of the process to generate clonally-derived cell ... more reliable solution when compared to traditional single ...
(Date:4/20/2017)... , April 20, 2017 ... "Global Biosimilar Pipeline and Market Prospects: Addressing Production ... report to their offering. ... "Global Biosimilar Pipeline and Market Prospects: ... Design" provides an in-depth assessment of the current trends ...
(Date:4/20/2017)... April 20, 2017  AbbVie (NYSE: ABBV), a ... (n=145/146) of chronic hepatitis C virus (HCV) infected ... 6 and compensated cirrhosis (Child-Pugh A) achieved sustained ... ) with its investigational, pan-genotypic regimen of glecaprevir/pibrentasvir ... seen following 12 weeks of G/P treatment without ...
Breaking Medicine Technology: